Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Response Evaluation”

199 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 199 results

Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Not applicableLooking for participantsNCT06756217
What this trial is testing

68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Ruijin Hospital 40
Not applicableUnknownNCT05787184
What this trial is testing

Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis

Who this might be right for
SepsisSeptic ShockShock
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 400
Not applicableStudy completedNCT00256490
What this trial is testing

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

Who this might be right for
Lymphoma, Large-Cell
Eric Turcotte 82
Large-scale testing (Phase 3)Study completedNCT00558883
What this trial is testing

AI(I)DA Acarbose and the Subclinical Inflammation

Who this might be right for
Type 2 Diabetes MellitusSubclinical Inflammation
GWT-TUD GmbH 104
Not applicableUnknownNCT00258869
What this trial is testing

Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests

Who this might be right for
SepsisSepticemiaSepsis Syndrome+2 more
National Center for Genome Resources 1,200
Not applicableStudy completedNCT01288287
What this trial is testing

Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Arthritis,Rheumatoid
UCB Pharma 149
Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Not applicableStudy completedNCT01974804
What this trial is testing

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 30
Not applicableEnded earlyNCT04082988
What this trial is testing

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

Who this might be right for
NSCLC, Stage IV
The Netherlands Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00857857
What this trial is testing

Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Who this might be right for
Asthma
GlaxoSmithKline 24
Not applicableLooking for participantsNCT05763277
What this trial is testing

Ate-Bev Early Response Prediction Model in Advanced HCC

Who this might be right for
Hepatocellular CarcinomaAtezolizumab-bevacizumabResponse Evaluation
Seoul National University Hospital 170
Not applicableNot Yet RecruitingNCT07111572
What this trial is testing

Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Fecal CalprotetinFIT
Qilu Hospital of Shandong University 100
Testing effectiveness (Phase 2)Study completedNCT00217139
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT01756352
What this trial is testing

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Who this might be right for
Glioblastoma MultiformeGBM
Marcelo F. Di Carli, MD, FACC 13
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Not applicableStudy completedNCT00748241
What this trial is testing

Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading

Who this might be right for
Jaw, Edentulous, Partially
Dentsply Sirona Implants and Consumables 19
Early research (Phase 1)WithdrawnNCT05774886
What this trial is testing

Implantable Microdevice for TNBC - Pilot Study

Who this might be right for
Triple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+4 more
Dana-Farber Cancer Institute
Not applicableStudy completedNCT07025603
What this trial is testing

Evaluation of the Social ABCs in Israel

Who this might be right for
AutismAutism Spectrum Disorder (ASD)
Hebrew University of Jerusalem 20
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Load More Results